NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Intellective Biologics (Suzhou) Co., Ltd.

Intellective Biologics (Suzhou) Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttp://intellectivebio.com/

Last Round

Series C

Extension

Jan 20, 2023

Est. Valuation

$873M

Total Funding Raised

$112M

Company Overview

Intellective Biologics (Suzhou) Co., Ltd. is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) providing one-stop services from process development to commercial manufacturing for biologics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Clinical Trials, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

contract development and manufacturing organizationCDMObiologics CDMObiologics manufacturinglarge molecule biologicsantibody-drug conjugatesADC manufacturingmonoclonal antibodiesprocess developmentcommercial manufacturingpharma supply chainmAb manufacturingdrug product developmentbispecific antibodiesrecombinant proteinsAI process developmentBiopharma 4.0

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intellective Biologics (Suzhou) Co., Ltd. Comparables

Compare Intellective Biologics (Suzhou) Co., Ltd. with similar companies based on industry and business-model similarity.

Intellective Biologics (Suzhou) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WuXi Biologics
85%
Innovent Biologics
80%
GenScript
80%

Intellective Biologics (Suzhou) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJan 20, 2023
Series CAug 4, 2022
Series B ExtensionSep 1, 2021
Series BJun 28, 2021
Series A ExtensionMay 7, 2021
Series A
Nov 1, 2020

Intellective Biologics (Suzhou) Co., Ltd. Investors

Notable investors and investment history

Intellective Biologics (Suzhou) Co., Ltd. investors
InvestorRounds
BioTrack CapitalSeries B, Series A, Series B Extension
Qingsong FundSeries A, Series B Extension
Legend CapitalSeries B, Series A, Series B Extension
Gaorong CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2021

    Raised capital from BioTrack Capital, Legend Capital, and Qingsong Fund.

Intellective Biologics (Suzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Intellective Biologics (Suzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Intellective Biologics (Suzhou) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Employee Range7
Year Founded2018
Last FundingJan 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.